KAYLEY HUFFMAN: Open Payments
NPI 1548938764 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,040 in 47 payments from 11 companies in 2025. Trend: 2023 $23 · 2024 $363 · 2025 $1,040
Food & beverage: $1,040
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 8 | $223 |
| Axsome Therapeutics, Inc. | 9 | $222 |
| Supernus Pharmaceuticals, Inc. | 6 | $152 |
| Collegium Pharmaceutical, Inc. | 5 | $94 |
| Tris Pharma Inc | 4 | $84 |
| Corium, LLC | 6 | $70 |
| ABBVIE INC. | 3 | $50 |
| Biogen, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
Products named: FANAPT, Auvelity, Qelbree, Jornay PM, Azstarys, Dyanavel XR, REXULTI, VRAYLAR.
Industry payments across MS — which companies pay providers there.
